Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04684264 · ClinicalTrials.gov registry record · NA
Feasibility of the Implementation of Tools for Heart Failure Risk Prediction
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 101
- Enrollment target
NCT04684264: Completed NA study, sponsored by Northwestern University.
NCT04684264 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 101 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04684264, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 101 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information to develop a heart failure screening and prevention program.
Primary Outcome
All participants will have brain natriuretic peptide (BNP) measured at baseline and at 1-year follow-up.
Interventions
- OTHER Heart Failure Prevention Clinic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2021-03-03 |
| Est. Completion | 2024-02-01 |
| Phase | NA |
What the finished NCT04684264 record still lists
NCT04684264 is an interventional study that assigns participants to a tested intervention. The registered 101 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Heart Failure Prevention Clinic is the first listed.
NCT04684264 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04684264 about?
NCT04684264 is a clinical study titled "Feasibility of the Implementation of Tools for Heart Failure Risk Prediction". The purpose of this study is to gather information to develop a heart failure screening and prevention program.
What is the current status of trial NCT04684264?
This trial is currently completed. It is a NA study. The enrollment target is 101 participants. The study started on 2021-03-03. Estimated completion is 2024-02-01.
What interventions are being tested in trial NCT04684264?
The interventions under investigation include: Heart Failure Prevention Clinic (OTHER).
Who is sponsoring clinical trial NCT04684264?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04684264's enrollment target sits among peer trials
101 840th of 2000 higher than 1,161 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04033497 · 101 participants · NA
Treatment Response Assessment Maps to Delineate Necrosis From Tumor After Stereotactic Radiation in Brain Metastases
- NCT05111574 · 101 participants · Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
- NCT05984680 · 101 participants
COPD Care Pathway Among Patients With Cancer
- NCT06266299 · 101 participants · Phase 1
A Study of KK2269 in Adult Participants With Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI